Cardiogenesis Corporation

As of May 17, 2011, Cardiogenesis Corporation was acquired by CryoLife Inc. Cardiogenesis Corporation develops laser transmyocardial revascularization technologies for the treatment of angina and ischemic cardiac diseases. It offers SoloGrip III, a minimally invasive transmyocardial revascularization fiberoptic delivery system; PEARL 5.0, a robotic handpiece delivery system; and SolarGen 2100s, a complete console and cardiovascular delivery system. The company also provides reimbursement services; and maintenance and warranty services. It offers its products to customers in the United States and internationally. Cardiogenesis Corporation was formerly known as Eclipse Surgical Technologies, Inc. and changed its name to Cardiogenesis Corporation in June 2001. The company was founded in 1989 and is headquartered in Kennesaw, Georgia.